Review
Accepted on 22 Nov 2024
Pharmacological inhibition of the MAP2K7 kinase in human disease
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1486756
Type at least 3 characters
2,922 articles
Articles
Review
Published on 19 Nov 2024
When a negative (charge) is not a positive: sialylation and its role in cancer mechanics and progression
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1487306
- 435 views
Brief Research Report
Published on 15 Nov 2024
Repurposing of PSMA-targeted diagnostic and therapeutic agents for the detection and treatment of giant cell tumors of bone
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1504514
- 289 views
Editorial
Accepted on 14 Nov 2024
Editorial: Unveiling the Potential of CTCs in Drug Resistance Mechanisms and Personalized Medicine
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1519816
Correction
Accepted on 13 Nov 2024
Corrigendum: Exogenous let-7a-5p induces A549 lung cancer cell death through BCL2L1-mediated PI3KÎł signaling pathway
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1513956
Original Research
Accepted on 12 Nov 2024
A real-world study: Third-line treatment options for metastatic colorectal cancer
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1480704
Retraction
Published on 12 Nov 2024
Retraction: MiR-365a-3p-mediated regulation of HELLS/GLUT1 axis suppresses aerobic glycolysis and gastric cancer growth
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1519833
- 164 views
Original Research
Accepted on 11 Nov 2024
Early in vitro Results Indicate that De-O-Acetylated Sialic Acids Increase Selectins Binding in Cancers
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1443303
Hypothesis and Theory
Published on 11 Nov 2024
The skeleton: an overlooked regulator of systemic glucose metabolism in cancer?
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1481241
- 296 views
Original Research
Accepted on 08 Nov 2024
circUBE2G1 Interacts with hnRNPU to Promote VEGF-C-Mediated Lymph Node Metastasis of Lung Adenocarcinoma
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1455909
Review
Published on 08 Nov 2024
The evolution of BRAF-targeted therapies in melanoma: overcoming hurdles and unleashing novel strategies
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1504142
- 458 views
Original Research
Accepted on 06 Nov 2024
Sialylation inhibition improves macrophage mediated tumor cell phagocytosis of breast cancer cells triggered by therapeutic antibodies of different isotypes
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1488668
Review
Published on 06 Nov 2024
Integrin α2 in the microenvironment and the tumor compartment of digestive (gastrointestinal) cancers: emerging regulators and therapeutic opportunities
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1439709
- 169 views
Original Research
Accepted on 05 Nov 2024
miR-198 targets TOPORS: implications for oral squamous cell carcinoma pathogenesis
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1485802
Correction
Accepted on 04 Nov 2024
Corrigendum: SERPIND1 Affects the Malignant Biological Behavior of Epithelial Ovarian Cancer via the PI3K/AKT Pathway: A Mechanistic Study
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1466959
Review
Published on 04 Nov 2024
Research progress of the SLFN family in malignant tumors
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1468484
- 284 views